FDA Licenses Sanofi Pasteur’s New Influenza Vaccine Delivered by Intradermal Microinjection

injection

Fluzone® Intradermal (Influenza Virus Vaccine) first to offer an immunization option with 90 percent smaller needle

The new formulation of Fluzone Intradermal vaccine is the first influenza vaccine licensed in the U.S. that uses a novel microinjection system for intradermal delivery. Fluzone Intradermal vaccine features an ultra-fine needle that is 90 percent shorter than the typical needle used for intramuscular injection of influenza vaccine.

Click to read press release

Date: 
Tuesday, May 10, 2011